Chemotherapeutic effect of CGI 18041 against subperiodic Brugia malayi infection in Presbytis cristata.
CGI 18041, an adduct of benzothiazol isothiocyanate N-methyl piperazine, was evaluated for its antifilarial properties in subperiodic Brugia malayi infected Presbytis cristata. Animals experimentally infected with 200-400 subperiodic Brugia malayi infective larvae, were matched according to microfilaria density, infective dose, and duration of infection. They were then randomly assigned to various treatment and control groups. The compound was suspended in 1% Tween 20 in distilled water, sonicated, and then fed to monkeys using a stomach tube. Control animals received an equivalent volume of drug diluent. CGI 18041 at a single oral dose of 50 mg/kg had complete adulticidal and microfilaricidal activities against subperiodic B. malayi in P. cristata. It was also extremely effective at a single dose of 25 mg/kg, the final geometric mean microfilaria count being 1.6% of initial level, and only 1.0% of the infective dose was recovered as live adult worms at autopsy 6 weeks post-treatment. In control animals, these were 226.9% and 5.56% respectively.
Mak
J W
JW
Institute for Medical Research, Kuala Lumpur, Malaysia.
Ngah
Z
Z
Choong
M F
MF
Navaratnam
V
V
D000284:Administration, Oral; D000818:Animals; D017178:Brugia malayi / Q000302:isolation & purification; D002520:Cercopithecidae; D004334:Drug Administration Schedule; D005368:Filariasis / Q000188:drug therapy* / Q000503:physiopathology; D005369:Filaricides / Q000008:administration & dosage / Q000627:therapeutic use*; D009930:Organic Chemicals; D010507:Periodicity
C070803:CGI 18041; D005369:Filaricides; D009930:Organic Chemicals